Safety of intra-operative blood salvage during liver transplantation in patients with hepatocellular carcinoma, a propensity score-matched survival analysis

Transplant International

Volumn 34, Issue 12, 2021, Pages 2887-2894

  Nutu, Oana Anisa ^a   Sneiders, Dimitri ^b   Mirza, Darius ^a   Isaac, John ^a   Perera, M Thamara P R ^a   Hartog, Hermien ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b University Medical Center Rotterdam   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLEEDING; BLOOD SALVAGE; BLOOD TRANSFUSION; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE FREE SURVIVAL; HUMAN; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MIDDLE AGED; MORTALITY RATE; PATIENT SAFETY; PROPENSITY SCORE; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; RISK ASSESSMENT; LIVER TUMOR; RISK FACTOR; SURVIVAL ANALYSIS; TUMOR RECURRENCE;

CARCINOMA, HEPATOCELLULAR; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; NEOPLASM RECURRENCE, LOCAL; OPERATIVE BLOOD SALVAGE; PROPENSITY SCORE; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 85118840251     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/tri.14150     Document Type: Article

References (24)

1. Carless PA, Henry DA, Moxey AJ, O'Connell D, Brown T, Fergusson DA. Cell salvage for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 2010; 17, CD001888.
2. Roets M, Sturgess DJ, Obeysekera MP, et al. Intraoperative cell salvage as an alternative to allogeneic (Donated) blood transfusion: a prospective observational evaluation of the immune response profile. Cell Transplant 2020; 29: 963689720966265.
3. Foltys D, Zimmermann T, Heise M, et al. Liver transplantation for hepatocellular carcinoma–is there a risk of recurrence caused by intraoperative blood salvage autotransfusion? Eur Surg Res 2011; 47: 182.
4. Muscari F, Suc B, Aguirre J, et al. Orthotopic liver transplantation with vena cava preservation in cirrhotic patients: is systematic temporary portacaval anastomosis a justified procedure? Transplant Proc 2005; 37: 2159.
5. Vamvakas EC, Blajchman MA. Transfusion-related immunomodulation (TRIM): an update. Blood Rev 2007; 21: 327.
6. Gharehbaghian A, Haque KM, Truman C, et al. Effect of autologous salvaged blood on postoperative natural killer cell precursor frequency. Lancet 2004; 363: 1025.
7. Kumar N, Chen Y, Zaw AS, et al. Use of intraoperative cell-salvage for autologous blood transfusions in metastatic spine tumour surgery: a systematic review. Lancet Oncol 2014; 15: e33.
8. Wu WW, Zhang WY, Zhang WH, et al. Survival analysis of intraoperative blood salvage for patients with malignancy disease: A PRISMA-compliant systematic review and meta-analysis. Medicine (Baltimore) 2019; 98: e16040.
9. Von Elm E, Altman D, Egger M, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 2008; 61: 344.
10. McKenna S. Autologous blood transfusions. Council on scientific affairs. JAMA 1986; 256: 2378.
11. Hansen E, Wolff N, Knuechel R, Ruschoff J, Hofstaedter F, Taeger K. Tumor cells in blood shed from the surgical field. Arch Surg 1995; 130: 387.
12. Kongsgaard UE, Wang MY, Kvalheim G. Leucocyte depletion filter removes cancer cells in human blood. Acta Anaesthesiol Scand 1996; 40: 118.
13. Martin RC, Wellhausen SR, Moehle DA, Martin AW, McMasters KM. Evaluation of intraoperative autotransfusion filtration for hepatectomy and pancreatectomy. Ann Surg Oncol 2005; 12: 1017.
14. Han S, Kim G, Ko JS, et al. Safety of the use of blood salvage and autotransfusion during liver transplantation for hepatocellular carcinoma. Ann Surg 2016; 264: 339.
15. Kumar N, Lam R, Zaw AS, et al. Flow cytometric evaluation of the safety of intraoperative salvaged blood filtered with leucocyte depletion filter in spine tumour surgery. Ann Surg Oncol 2014; 21: 4330.
16. DiNorcia J, Florman SS, Haydel B, et al. Pathologic response to pretransplant locoregional therapy is predictive of patient outcome after liver transplantation for hepatocellular carcinoma: analysis from the US multicenter HCC transplant consortium. Ann Surg 2020; 271: 616.
17. Manzia TM, Lai Q, Iesari S, et al. Impact of remnant vital tissue after locoregional treatment and liver transplant in hepatocellular cancer patients, a multicentre cohort study. Transpl Int 2018; 31: 988.
18. Pinto MA, Chedid MF, Sekine L, et al. Intraoperative cell salvage with autologous transfusion in liver transplantation. World J Gastrointest Surg 2019; 11: 11.
19. Feltracco P, Brezzi M, Barbieri S, et al. Blood loss, predictors of bleeding, transfusion practice and strategies of blood cell salvaging during liver transplantation. World J Hepatol 2013; 5: 1.
20. Blajchman MA, Bordin JO. The tumor growth-promoting effect of allogeneic blood transfusions. Immunol Invest 1995; 24: 311.
21. Tai YH, Wu HL, Mandell MS, Tsou MY, Chang KY. The association of allogeneic blood transfusion and the recurrence of hepatic cancer after surgical resection. Anaesthesia 2020; 75: 464.
22. Araujo RL, Pantanali CA, Haddad L, Rocha Filho JA, D'Albuquerque LA, Andraus W. Does autologous blood transfusion during liver transplantation for hepatocellular carcinoma increase risk of recurrence? World J Gastrointest Surg 2016; 8: 161.
23. Catling S, Williams S, Freites O, Rees M, Davies C, Hopkins L. Use of a leucocyte filter to remove tumour cells from intra-operative cell salvage blood. Anaesthesia 2008; 63: 1332.
24. Kemper RR, Menitove JE, Hanto DW. Cost analysis of intraoperative blood salvage during orthotopic liver transplantation. Liver Transpl Surg 1997; 3: 513.